MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14728222.2017.1258402

Медицинская библиотека · Expert opinion on therapeutic targets · 2016

Tumor necrosis factor-α in Guillain-Barré syndrome, friend or foe?

Wang Ying, Zhang Jingdian, Luo Peijuan, Zhu Jie, Feng Jiachun, Zhang Hong-Liang

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Guillain-Barré syndrome (GBS) is an immune-mediated disorder in the peripheral nervous system (PNS), and experimental autoimmune neuritis (EAN) serves as an animal model of GBS. TNF-α plays an important role in the pathogenesis of GBS and is a potential therapeutic target of GBS. Areas covered: 'TNF-α' and 'Guillain-Barré syndrome' were the keywords used to search for related publications on Pubmed. By binding to different TNF receptors, TNF-α bears distinct immune properties. TNF-α gene polymorphisms are associated with the features of GBS. The major role of TNF-α in GBS/EAN is to aggravate inflammation; however, data from several studies indicated a protective role of TNF-α. Multiple lines of evidence point to TNF-α as a potential therapeutic target for GBS. However, such clinical trials are scarce in that GBS per se is a probable side effect of anti-TNF-α treatment. Expert opinion: TNF-α plays a dual role in GBS and EAN, and is a potential therapeutic target on GBS/EAN.

Для цитирования: Wang Ying, Zhang Jingdian, Luo Peijuan, Zhu Jie, Feng Jiachun, Zhang Hong-Liang. Tumor necrosis factor-α in Guillain-Barré syndrome, friend or foe?. Expert opinion on therapeutic targets. 2016. DOI: 10.1080/14728222.2017.1258402.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.